Richard D. Peterson
Director/Board Member presso UNIVERSAL INSURANCE HOLDINGS, INC.
Patrimonio netto: 418 409 $ in data 31/03/2024
Profilo
Richard D.
Peterson is currently an Independent Director at Universal Insurance Holdings, Inc. He is also a Member at The Financial Executives Institute and the Chief Financial Officer at Turn Biotechnologies, Inc. Mr. Peterson previously worked as the Director at The Arizona Center For Nature Conservation.
He was also the Chief Financial Officer, Treasurer & Executive VP at Medicis Pharmaceutical Corp.
from 2011 to 2012.
Before that, he worked as a Senior Financial Auditor at PricewaterhouseCoopers LLP from 1992 to 1995.
Mr. Peterson has also served as the Chief Financial Officer at Clarus Therapeutics, Inc., NVN Liquidation, Inc., Botanix Pharmaceuticals Ltd., Sienna Biopharmaceuticals, Inc., Dermavant Sciences, Inc., and Clarus Therapeutics Holdings, Inc. He completed his undergraduate degree from Arizona State University in 1992.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 20/06/2023 | 20 591 ( 0.07% ) | 418 409 $ | 31/03/2024 |
Posizioni attive di Richard D. Peterson
| Società | Posizione | Inizio |
|---|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Director/Board Member | 05/06/2014 |
| The Financial Executives Institute | Corporate Officer/Principal | 26/05/2009 |
Precedenti posizioni note di Richard D. Peterson
| Società | Posizione | Fine |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Director of Finance/CFO | 31/08/2022 |
| BOTANIX PHARMACEUTICALS LIMITED | Director of Finance/CFO | 01/05/2020 |
| SIENNA BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 29/03/2018 |
| NVN LIQUIDATION, INC. | Director of Finance/CFO | 23/03/2017 |
Formazione di Richard D. Peterson
| Arizona State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Finance |
| NVN LIQUIDATION, INC. | Health Technology |
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
| The Financial Executives Institute | |
The Arizona Center For Nature Conservation
 The Arizona Center For Nature Conservation Other Consumer ServicesConsumer Services The Arizona Center For Nature Conservation provides conservatory of animals and habitats. The company was founded by Robert E. Maytag in 1961 and is headquartered in Phoenix, AZ. | Consumer Services |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
- Borsa valori
- Insiders
- Richard D. Peterson
